⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Shilpa Biologicals Pvt. Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Shilpa Biologicals Pvt. Ltd.
↗Dharwad, India
Shilpa Biologicals is a fully integrated biopharmaceutical company and a subsidiary of Shilpa Medicare Limited. Operating as a hybrid CDMO/pharma company, it specializes in the development and manufacturing of high-quality, affordable biologics, including biosimilars, fusion proteins, and vaccines, with a therapeutic focus on immunology, oncology, ophthalmics, and hematology.
The company operates a state-of-the-art R&D and manufacturing facility in Dharwad, Karnataka, India. Its capabilities span the entire value chain from gene-to-cell line development, process development, and analytical characterization to large-scale commercial manufacturing (mammalian and microbial) and fill-finish services for global clients.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$10M-$20M
Founded:2020
Ownership:subsidiary
Status:operating
FUNDING
Investors:Shilpa Medicare Limited (Parent)
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:Biosimilars, Fusion proteins, Monoclonal antibodies, ADCs, Vaccines
Active Trials:0
Trial Phases:Phase 3: 3
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Shilpa Medicare Limited
Key Partnerships:SteinCares (Licensing agreement for Latin America), mAbTree Biologics AG (Development of novel immuno-oncology assets)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Madhav Bhutada - Director
LINKS
Website:shilpabio.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Shilpa Biologicals Pvt. Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.